BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8615587)

  • 1. Effect of oxymetazoline nose drops on acute sinusitis in the rabbit.
    Bende M; Fukami M; Arfors KE; Mark J; Stierna P; Intaglietta M
    Ann Otol Rhinol Laryngol; 1996 Mar; 105(3):222-5. PubMed ID: 8615587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oxymetazoline on nasal and sinus mucosal blood flow in the rabbit as measured with laser-Doppler flowmetry.
    Akerlund A; Arfors KE; Bende M; Intaglietta M
    Ann Otol Rhinol Laryngol; 1993 Feb; 102(2):123-6. PubMed ID: 8427497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between ostial patency and medical treatment in acute maxillary sinusitis: an experimental study].
    Kutluhan A; Inalkaç E; Kiroğlu AF; Akpolat N; Kiriş M
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(4):275-81. PubMed ID: 12422083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose drops induce vasomotion in the microcirculation of the sinus mucosa of the rabbit.
    Bende M; Arfors KE; Intaglietta M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):110-3. PubMed ID: 7680443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental acute sinusitis in rabbits. A bacteriological and histological study.
    Johansson P; Kumlien J; Carlsöö B; Drettner B; Nord CE
    Acta Otolaryngol; 1988; 105(3-4):357-66. PubMed ID: 3389121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
    Suh SH; Chon KM; Min YG; Jeong CH; Hong SH
    Acta Otolaryngol; 1995 Sep; 115(5):664-71. PubMed ID: 8928640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of oxymetazoline in nasal endoscopic sinus surgery].
    Zhen H; Gao Q; Cui Y; Hua X; Li H; Feng J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 May; 17(5):281-2. PubMed ID: 12916356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of nasal bacterial culture for etiological agents in acute maxillary sinusitis.
    Savolainen S; Ylikoski J; Jousimes-Somer H
    Rhinology; 1987 Mar; 25(1):49-55. PubMed ID: 3554464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
    Ackerhans M; Jannert M; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis.
    Graf P; Enerdal J; Hallén H
    Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1128-32. PubMed ID: 10522506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
    Druce HM; Ramsey DL; Karnati S; Carr AN
    Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth.
    Hersh EV; Pinto A; Saraghi M; Saleh N; Pulaski L; Gordon SM; Barnes D; Kaplowitz G; Bloom I; Sabti M; Moore PA; Lee S; Meharry M; He DY; Li Y
    J Am Dent Assoc; 2016 Apr; 147(4):278-87. PubMed ID: 26822100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental acute sinusitis in rabbit. A study of mucosal blood flow.
    Drettner B; Johansson P; Kumlien J
    Acta Otolaryngol; 1987; 103(5-6):432-4. PubMed ID: 3618170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of oxymetazoline administered with a nasal bellows container and combined with oral phenoxymethyl-penicillin in the treatment of acute maxillary sinusitis.
    Wiklund L; Stierna P; Berglund R; Westrin KM; Tönnesson M
    Acta Otolaryngol Suppl; 1994; 515():57-64. PubMed ID: 8067245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.
    Eskiizmir G; Hirçin Z; Ozyurt B; Unlü H
    Eur J Clin Pharmacol; 2011 Jan; 67(1):19-23. PubMed ID: 21069518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
    Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
    J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.